Background. The case fatality rate (CFR) from invasive meningococcal disease (IMD) in New York City (NYC) is greater than national figures, with higher rates among females than males across all age groups.
Invasive meningococcal disease (IMD) is a rare yet serious infection caused by the Gram-negative bacterium Neisseria meningitidis. The clinical spectrum of IMD is wide, and the progression of disease can be swift. Antibiotic administration is recommended as soon as the diagnosis is suspected, before blood and/or spinal fluid cultures are obtained [1] .
Meningitis is the most common presentation of IMD, occurring in approximately 50% of patients, with a mortality rate of 5%-18% [2] . Meningococcemia, the most severe form of the disease, occurs in approximately 20% of patients and has a mortality rate approaching 30% [3] . Fever, headache, stiff neck, photophobia, and altered mental status are hallmark signs of meningitis and prompt clinicians to consider bacterial etiologies and obtain diagnostic tests. In contrast, clinical recognition of bacteremia and early sepsis is not straightforward [4] , and in the absence of petechiae, the consideration of IMD may be dismissed or delayed [5] .
The IMD case fatality rate (CFR) in New York City (NYC) increased from 16% (n = 49/313) in the years 2000-2007 to 25% (n = 43/173) in the years 2008-2016. The CFR among males (all ages) increased from 14% (n = 22/152) to 18% (n = 19/107), whereas the CFR among females increased from 17% (n = 27/161) to 36% (n = 24/66). By comparison, the IMD CFR in the United States for the years 2008-2015 is estimated to have been 15% [6] , and no sex disparity has been noted (J. MacNeil, Centers for Disease Control and Prevention, personal communication with D. Weiss, 8 March 2017) . Previously identified risk factors for IMD fatality include older age (particularly ≥60 years) [7] [8] [9] , infection with serogroup C [10, 11] , and indicators of vascular leakage, such as thrombocytopenia, petechiae, and purpura [7] [8] [9] .
Early administration of antibiotics results in negative cultures in 32%-57% of patients [12, 13] , and we explored whether unreported, culture-negative meningococcal meningitis cases could contribute to the higher NYC CFR [14] and if reporting of suspect IMD in NYC is deficient [15] . However, the contribution of undiagnosed cases to IMD CFR in NYC remains largely unknown. Invasive meningococcal disease mortality has been noted to be higher during outbreaks [16] , and 2 IMD outbreaks have occurred in NYC since 2000: one in 2005-2006, predominately among current and recovering drug users and their close contacts [17] ; and the other in 2010-2013, exclusively among men who have sex with men [18] . We examined IMD surveillance data for the period 2008-2016 to characterize sex differences in presentation and outcome, to confirm the elevated risk of mortality among female patients after adjusting for confounding factors, and to identify risk factors for death among females.
METHODS

Study Population
All suspected and confirmed cases of IMD in NYC are reportable to the Department of Health and Mental Hygiene (DOHMH). Reported cases are immediately investigated by DOHMH's Bureau of Communicable Disease to identify close contacts requiring antibiotic prophylaxis and to collect epidemiologic data for use in cluster and outbreak detection. New York City residents aged ≥15 years who met the Council of State and Territorial Epidemiologists case definition for confirmed or probable IMD [19] , were diagnosed from 2008-2016, and were reported to DOHMH were included in this analysis. Patients aged <15 years of age were excluded because disease manifestation and mortality often differs between children and adults [20] . Cases diagnosed prior to 2008 were excluded because data collection for certain clinical variables during this period was incomplete.
All reports of IMD were investigated using a standardized data collection tool that incorporated chart abstraction and patient or proxy interview. Data on patient death were collected at the time of investigation, and all patients were matched with DOHMH's Office of Vital Statistics death registry. Death attributable to IMD was defined as death within 30 days of disease diagnosis with an underlying cause consistent with IMD on the death certificate. Data on hepatitis C virus (HCV) coinfection were obtained from the Bureau of Communicable Disease surveillance database. Human immunodeficiency virus (HIV) coinfection was determined by matching to the NYC HIV Surveillance Registry [21] . Census tract-level poverty data, defined as percentage of residents with incomes below 100% of the federal poverty level, were obtained from the 2010-2014 American Community Survey [22] .
Syndromes were defined by the specimen source(s) positive for N. meningitidis (blood = bacteremia, cerebrospinal fluid = meningitis, joint fluid = arthritis, pleural fluid = pneumonia) and were not mutually exclusive. Pneumonia was additionally defined as a positive blood culture with a radiographic reading of pneumonia. Meningococcemia was defined as presentation with shock, purpura, or systolic blood pressure ≤100 mmHg with platelet count ≤100 × 10 3 /µL and was mutually exclusive with bacteremia. Appropriate antibiotics for IMD treatment were defined as antibiotics to which N. meningitidis is susceptible [23] .
For culture-positive cases, IMD serogroup was determined by slide agglutination at the NYC Public Health Laboratory before 2016 and by real-time polymerase chain reaction (PCR) in 2016. The diagnosis and serogroup for culture-negative cases was determined from clinical specimens (blood, cerebrospinal fluid, etc.) by real-time PCR at the New York State Department of Health Wadsworth Center.
Statistical Analysis
Invasive meningococcal disease characteristics by sex were compared using descriptive statistics, the χ 2 , test or Fisher's exact test for categorical variables and the Mann-Whitney test for continuous variables with non-normal distributions. Kaplan-Meier curves and the log-rank test were used to compare 30-day IMD survival of females versus males. A retrospective cohort design was used to analyze risk factors for death from IMD. Bivariate and multivariable log-linear Poisson regression models with robust error variance were used to model associations between patient characteristics and death [24] . Three multivariable models were developed: 1 that included demographic variables (eg, sex, age, neighborhood-level poverty, race/ethnicity), 1 that included clinical variables (eg, symptoms, serogroup, comorbidities) in addition to demographic variables, and 1 that included clinical and demographic variables limited to only female patients. The purpose of the first multivariable model was to assess whether unrecognized demographic and community-level variables were associated with death from IMD. The second multivariable model added clinical variables available at emergency department (ED) presentation or soon thereafter and served to evaluate markers of disease severity that may inform clinical decision making with risk of death from IMD. A third multivariable model restricted to only females assessed associations between clinical and demographic factors and death to examine indicators of fatality among females.
Variables with P < .10 in the bivariate analysis were eligible for inclusion in final multivariable models; variables with known or plausible associations with the outcome were included a priori (age, serogroup, race/ethnicity, neighborhood-level poverty). Variables with >20% missing data were analyzed at a bivariate level but were not eligible for inclusion in final multivariable models. Multivariable models were created using backward elimination. Because log-linear Poisson regression with robust error variance has limited model-fit statistics, models were first built using log-linear Poisson regression without robust error variance, which yields more conservative confidence intervals [24] . Covariates that were not significant at P < .10 were removed, and models were compared using the likelihood-ratio test. Interaction terms between sex and covariates included in the final model were also evaluated to further examine factors influencing IMD mortality by sex. The best-fit model was then reassessed using log-linear Poisson regression with robust error variance, and significance was considered to be P < .05. Analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC) statistical software, and Kaplan-Meier curves were produced using the survival and rms software packages in R version 3.2.4.
RESULTS
The incidence of IMD in NYC decreased from 0.3 per 100 000 persons in 2008 to 0.1 per 100 000 persons in 2016. The average annual incidence from 2008-2016 was 0.2 per 100 000 persons for females and 0.3 per 100 000 persons for males. During this interval, there were 151 cases of IMD reported among NYC residents aged ≥15 years, of whom 89 (59%) were male and 40 (27%) died. The overall CFR was 37% (n = 23/62) among females and 19% (n = 17/89) among males (P = .01). The CFR for both females and males fluctuated but declined as a whole over the period (Table 1) . Survival probability from IMD among females declined 3 days after symptom onset compared with males (P = .02) (Figure 1 ), and the CFR among females exceeded that of males in each age group (Table 2) . Females with IMD were older than males (median age, 53 vs 35 years; P < .001), whereas males more commonly presented with meningitis (43% vs 28%; P = .06), had previously diagnosed HIV (27% vs 0%; P < .001) and had a higher proportion of N. meningitidis serogroup C (43% vs 21%; P = .08) ( Table 2 ). Eleven percent of cases had received a meningococcal vaccine prior to IMD onset; all vaccinated cases survived their illness. Vaccination rates did not differ significantly between females and males (6% vs 15%; P = .14). The median interval from onset to hospitalization was 1 day (range, 0-14), and the median interval from ED triage to appropriate antibiotic treatment was 3.4 hours (range, 0.1-720.9). These intervals did not differ significantly between females and males.
In the demographic multivariable logistic regression model, controlling for race/ethnicity, age, and neighborhood-level poverty, females had 2.1 times the risk of death (95% CI, 1.2-3.8) from IMD as males (Table 3) . After controlling for age, race/ ethnicity, neighborhood-level poverty, serogroup, altered mental status, petechiae, HCV, and shock, there was a significant interaction between sex and meningitis (P = .02). Among those with meningitis, females were 13.7 times as likely to die as males (95% CI, 3.2-58.1), whereas among those without meningitis, females were 1.9 times as likely to die as males (95% CI, 1.1-3.5) ( Table 4) . Females with meningitis were hospitalized on the weekend more frequently (41% vs 16%; P = .08) and waited longer to seek care (median, 2 vs 1 day; P = .10) compared with males with meningitis (data not shown). Figure 1 . Invasive meningococcal disease (IMD) survival probability in males compared with females aged ≥15 years, New York City, 2008-2016. Survival probability from IMD diverged between females and males after 3 days post-symptom onset, with females having a significantly lower probability of surviving than males (log-rank P = .02). b n = 59 among females and n = 83 among males.
c n = 39 among females and n = 66 among males.
d Not mutually exclusive groups.
e n = 45 among females and n = 71 among males.
f n = 44 among females and n = 69 among males. g n = 61 among females and n = 85 among males.
h n = 61 among females and n = 84 among males. CI, 1.6-9.0). In the female-only multivariable model, altered mental status (aRR, 7.5; 95% CI, 2.9-19.6) and infection with serogroup W (aRR, 3.6; 95% CI, 1.1-11.9) emerged as independent risk factors for death (Table 5 ). Presentation on weekends, onset to presentation interval, time to antibiotics, and coinfection with HCV were not significant in the female-only multivariable model.
DISCUSSION
The IMD CFR in NYC is higher than the national rate, and females with IMD in NYC had more than twice the risk of death compared with males, independent of age, race/ethnicity, and neighborhood-level poverty. The IMD survival probabilities were similar between females and males until after 3 days post-symptom onset, when survival probability declined more for females than males. There were no significant differences between sexes in time from symptom onset to hospitalization, time from ED triage to appropriate antibiotic treatment, or vaccination rates. After controlling for serogroup, clinical factors, and demographic characteristics, there was a significant interaction between sex and meningitis: females with meningitis were 13 times as likely to die as males, whereas females without meningitis were twice as likely to die as males. In the femaleonly model, altered mental status was independently associated with higher risk of death.
Although the literature on sex differences in IMD mortality is sparse, at least 2 instances of increased IMD mortality among females have been noted. In the Netherlands, death from IMD among females was 2.3 (95% CI, 1.2-4.7) times that of males from 1989 to 1990, controlling for age and clinical presentation. The female CFR was highest compared with males in the 10-19 years and the ≥50 years age groups, prompting the authors to speculate a hormonal source impacting immune function for the increased CFR [25] , which has been suggested as a source of differential sex CFRs for other infectious disease [26] . In Catalonia, Spain, an increased odds of death from IMD among females (OR, 1.5; 95% CI, 1.1-2.1) was noted from 1990 to 1997 in bivariate analysis but was not significant after controlling for age and clinical presentation [27] . If hormonal differences predispose females to IMD mortality, it stands to reason this finding would be reproducible across studies and countries; however, a review of the published literature (articles reporting on >500 cases) failed to find additional reports of an increased female CFR.
It is also unlikely that the 2010-2013 outbreak among men who have sex with men was the source of the observed sex disparity: although higher CFRs have been noted in outbreaks [16] , the female CFR remained higher than that of outbreak cases during this period. In response to the outbreak, >20 000 men were vaccinated [18] . Were this to have had an effect on the observed sex mortality difference, we would expect that mortality among males would have declined more than among females, which was not the case.
A significant interaction between sex and meningitis in our multivariable model revealed that risk of death for females with meningitis was >13 times that of males with meningitis. Meningococcal meningitis is typically associated with lower CFRs relative to other IMD syndromes [2] because its presentation is more easily recognized and diagnosed. Females with meningitis in our study were admitted to the hospital on weekends more frequently than males with meningitis. The "weekend effect, " or worse outcomes for patients hospitalized on weekends, has been identified with emergency admissions [28] , potentially due to decreased hospital staffing and service ability; however, we did not find a weekend effect in the female-only analysis. Females with meningitis in our study also sought care a median 1 day later post-symptom onset than males with meningitis, and poorer outcomes have been linked with delays in seeking care [29] . Although the unusually high CFR among females with meningitis contributes to the overall elevated risk of IMD fatality among females, it does not entirely account for the observed disparity.
Although altered mental status is considered part of the "classic triad of meningitis" symptoms, along with fever and stiff neck [30] , our findings suggest that altered mental status can also be an important indicator of severe IMD, particularly among females. Altered mental status may be an early presenting sign of sepsis [31] and may occur in more than one fifth of patients [32] . Patients without underlying comorbidities presenting with altered mental status should trigger providers to consider sepsis and evaluate for IMD, particularly in conjunction with decreased systolic blood pressure and increased respiratory and heart rates.
Death from IMD is primarily from meningococcemia, and outcome studies of bacterial sepsis have been inconclusive regarding existence of a sex bias [33] , although several studies have found a sex-based disparity in the quality of acute care for sepsis [34, 35] . Within acute hospital settings, sex disparities have been observed in administering appropriate and timely treatment for conditions such as stroke [36] and acute coronary syndrome [37] , which like IMD, have outcomes highly dependent on rapid intervention. Although negative outcomes have been associated with delays in seeking care or receiving treatment [29] , the interval from onset to hospitalization was not significant in either our model comparing females with males or the female-only model, suggesting that delay in seeking care does not explain our observed sex difference in CFR. There are several other factors beyond antibiotics that influence IMD outcomes, such as fluid management and administration of inotropic agents, which we were not able to capture in this study but should be examined for sex-based biases. Coinfection with HCV was significantly associated with increased risk of IMD fatality in our multivariable analysis, which, to our knowledge, has not been previously reported. However, increased risk of death among patients coinfected with invasive Streptococcus pneumoniae and HCV [38] , as well as among cirrhotic HCV patients with severe sepsis [39] , has been found. Hepatitis C virus proteins have been found to inhibit complement component C9 expression [40] , which is involved in the membrane attack complex of the terminal complement pathway; deficiencies in the terminal complement systems have been linked with a predisposition to IMD [41] . Further investigation is necessary to examine the relationship between HCV and IMD progression and outcome.
Strengths of this study include the thorough case investigations, chart reviews, and matching with HCV, HIV, and Office of Vital Statistics registries, which allowed us to account for several potential confounders to confirm the elevated female IMD mortality. Our study is limited by the small number of IMD cases that occurred and therefore may be underpowered to detect some differences in the multivariable models. Data on underlying conditions beyond HIV, HCV, diabetes, and cancer were not consistently collected in the early years of the study, which limited our ability to adjust for additional possible confounders that may increase risk of IMD death. The data collection form was modified during the study period, which may have affected completeness of variables describing vital signs and time of antibiotic administration in earlier study years, but we do not expect these missing data are differentially absent from those who died versus those who survived. Additionally, the 4 patients who were found dead or were dead on arrival have missing clinical information, which may bias our estimates toward the null. Finally, the Kaplan-Meier method assumes minimal left-censoring, and our results may be influenced by imprecision in defining onset dates due to patient recall, proxy interview, or mild early symptoms.
From our data, we are not able to determine whether a sex disparity exists in quality of IMD treatment. For practitioners in NYC, our findings emphasize the need for astute recognition and rapid treatment of IMD, particularly among females in ED and during the initial days of intensive care unit care. Given the decreasing IMD incidence in NYC and nationwide, further examination is required to describe the changing epidemiology of IMD and identify emerging risk groups. We intend to analyze NYC IMD surveillance data over the past 3 decades to better identify patterns in serogroup, fatality, sex, and syndrome.
Notes
